Search
Colletotrichum coccodes
go.drugbank.com/drugs/DB10824ApprovedColletotrichum coccodes is a fungus which can provoke allergic reactions. Colletotrichum coccodes extract is used in allergenic testing.
Mixtures: Treatment Set TS128871Pranlukast
go.drugbank.com/drugs/DB01411InvestigationalIt antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens. … Pranlukast is a cysteinyl leukotriene receptor-1 antagonist.
Rinucumab
go.drugbank.com/drugs/DB16313InvestigationalRinucumab is under investigation in clinical trial NCT02418754 (Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-related Macular Degeneration (AMD)).
Trimethadione
go.drugbank.com/drugs/DB00347ApprovedWithdrawnAn anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
Methoxamine
go.drugbank.com/drugs/DB00723ApprovedInvestigationalWithdrawnAn alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system.
Lancovutide
go.drugbank.com/drugs/DB05029InvestigationalLantibiotics are bacteriocins that are characterized by the presence of a high proportion of unusual amino acids. … Lancovutide, a peptide antibiotic, is in clinical development for the treatment of cystic fibrosis.
Foreskin keratinocyte (neonatal)
go.drugbank.com/drugs/DB10772ApprovedWhen an epidermal layer was added, this approach became known as "skin equivalent", "composite culture" or "organotypical culture" [L2453]. … Foreskin keratinocytes are an important ingredient in several skin substitutes [L2460], used for various indications.
Elasomeran
go.drugbank.com/drugs/DB15654ApprovedInvestigational[L28026] On December 23, 2020, Health Canada issued an expedited authorization for the Moderna COVID-19 Vaccine. … [L28026] On December 18, 2020, the FDA first issued an emergency use authorization (EUA) for the Moderna COVID-19 Vaccine as the second vaccine for the prevention of COVID-19 caused by SARS-CoV-2 in
Khuskia oryzae
go.drugbank.com/drugs/DB10581ApprovedKhuskia oryzae is a fungus which can provoke allergic reactions. Khuskia oryzae extract is used in allergenic testing.
Mixtures: Treatment Set TS128871